A randomised, double-masked comparison study of diquafosol versus sodium hyaluronate ophthalmic solutions in dry eye patients

British Journal of Ophthalmology

Volumn 96, Issue 10, 2012, Pages 1310-1315

  Takamura, Etsuko ^a   Tsubota, Kazuo ^b   Watanabe, Hitoshi ^c   Ohashi, Yuichi ^d  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c KANSAI ROSAI HOSPITAL   (Japan)

^d EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DIQUAFOSOL; FLUORESCEIN; HYALURONIC ACID; ROSE BENGAL;

ADULT; ARTICLE; BLEPHARITIS; CONJUNCTIVAL HYPEREMIA; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; DRY EYE; EYE DISCHARGE; EYE DISCOMFORT; EYE IRRITATION; EYE PAIN; FEMALE; HUMAN; INTRAOCULAR FOREIGN BODY; INTRAOCULAR PRESSURE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OCULAR PRURITUS; OPHTHALMOLOGY; OPHTHALMOSCOPY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SIDE EFFECT; STAINING; VISUAL ACUITY;

CORNEA; DOUBLE-BLIND METHOD; DRY EYE SYNDROMES; FLUORESCEIN; FLUORESCENT DYES; HUMANS; HYALURONIC ACID; OPHTHALMIC SOLUTIONS; POLYPHOSPHATES; ROSE BENGAL; TREATMENT OUTCOME; URACIL NUCLEOTIDES; VISCOSUPPLEMENTS;

EID: 84867088231     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjophthalmol-2011-301448     Document Type: Article

References (23)

1. Lemp MA, Baudouin C, Baum J, et al. The definition and classification of dry eye disease: report of the definition and classification subcommittee of the international Dry Eye WorkShop (2007). Ocular Surface 2007;5:75-92. (Pubitemid 351902651)
2. Dilly PN. Structure and function of the tear film. Adv Exp Med Biol 1994;350:239-47. (Pubitemid 24130636)
3. Watanabe H. Significance of mucin on the ocular surface. Cornea 2002;21:S17-22. (Pubitemid 34188772)
4. Lemp MA. Report of the National Eye Institute/Industry workshop on Clinical Trials in Dry Eyes. CLAO J 1995;21:221-32.
5. Danjo Y, Watanabe H, Tisdale AS, et al. Alteration of mucin in human conjunctival epithelia in dry eye. Invest Ophthalmol Vis Sci 1998;39:2602-9. (Pubitemid 28558219)
6. Ishida R, Kojima T, Dogru M, et al . The application of a new continuous functional visual acuity measurement system in dry eye syndromes. Am J Ophthalmol 2005;139:253-8. (Pubitemid 40288269)
7. Miljanovic B, Dana R, Sullivan DA, et al. Impact of dry eye syndrome on vision-related quality of life. Am J Ophthalmol 2007;143:409-15.e2.
8. Pflugfelder SC, Geerling G, Kinoshita S, et al. Management and therapy of dry eye disease: report of the management and therapy subcommittee of the international Dry Eye WorkShop (2007). Ocular Surface 2007;5:163-78. (Pubitemid 351902655)
9. Nakamura M, Hikida M, Nakano T, et al. Characterization of water retentive properties of hyaluronan. Cornea 1993;12:433-6. (Pubitemid 23249325)
10. Nakamura M, Mishima H, Nishida T, et al. Binding of hyaluronan to plasma fibronectin increases the attachment of corneal epithelial cells to a fibronectin matrix. J Cell Physiol 1994;159:415-22. (Pubitemid 24188981)
11. Shimmura S, Ono M, Shinozaki K, et al. Sodium hyaluronate eyedrops in the treatment of dry eyes. Br J Ophthalmol 1995;79:1007-11.
12. Sall K, Stevenson OD, Mundorf TK, et al. Two multicenter randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. Ophthalmology 2000;107:631-9. (Pubitemid 30191329)
13. Stevenson D, Tauber J, Reis BL. Efficacy and safety of cyclosporin A ophthalmic emulsion in the treatment of moderate-to-servere dry eye disease: a dose-ranging, randomized trial. Ophthalmology 2000; 107:967-74.
14. 2 receptor gene expression by in situ hybridization. Exp Eye Res 2003;77:77-84.
15. Hosoya KI, Ueda H, Kim KJ, et al. Nucleotide stimulation of Cl-secretion in the pigmented rabbit conjunctiva. J Pharmacol Exp Ther 1999;291:53-9. (Pubitemid 29451572)
16. 2 nucleotide receptors in rabbit and human conjunctiva. Exp Eye Res 1998;67:341-6.
17. Pendergast W, Yerxa BR, Douglass JG, et al. Synthesis and P2Y receptor activity of a series of uridine dinucleoside 5′-polyphosphates. Bioorg Med Chem Lett 2001;11:157-60. (Pubitemid 32099630)
18. 2 agonist INS365 in a rat dry eye model. Invest Ophthalmol Vis Sci 2001;42:96-100.
19. Fujihara T, Murakami T, Nagano T, et al. INS365 suppresses loss of corneal epithelial integrity by secretion of mucin-like glycoprotein in a rabbit short-term dry eye model. J Ocul Pharmacol Ther 2002;18:363-70. (Pubitemid 34977658)
20. 2 receptor agonists on Schirmer scores in rabbits. Adv Exp Med Biol 2002;506:261-5.
21. Tauber J, Davitt WF, Bokosky JE, et al. Double-masked, placebo-controlled safety and efficacy trial of diquafosol tetrasodium (INS365) ophthalmic solution for the treatment of dry-eye. Cornea 2004;23:784-92. (Pubitemid 39447308)
22. Feenstra RPG, Tseng SCG. What is actually stained by rose bengal? Arch Ophthalmol 1992;110:984-93.
23. Feenstra RPG, Tseng SCG. Comparison of fluorescein and rose bengal staining. Ophthalmology 1992;99:605-17.